Glenmark Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Postal Ballot. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.
GLENMARK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Glenmark Pharmaceuticals has announced the results of a postal ballot conducted via remote e-voting from July 3 to August 1, 2025. The single resolution was to appoint Mr. Anurag Mantri (DIN: 05326463) as Whole-time Director, designated as 'Executive Director and Global Chief Financial Officer.' Out of 1,93,671 eligible members holding 28.22 crore shares, 1,330 members holding 23.39 crore shares (82.89% of paid-up equity capital) cast their votes. The resolution was passed with overwhelming support — 97.25% of valid votes were cast in favour (22.74 crore shares) versus only 2.75% against (64.32 lakh shares). Promoter group voted 100% in favour, public institutions voted 93.43% in favour, and public non-institutions voted 99.95% in favour.
Mr. Anurag Mantri's appointment as Executive Director and Global CFO is now formally confirmed by shareholders, finalising the company's top finance leadership. The near-unanimous approval signals strong shareholder confidence in the leadership appointment and is unlikely to have any negative impact on the stock price.